quemliclustat
Showing 1 - 6 of 6
Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)
Not yet recruiting
- Biliary Tract Carcinoma
- +2 more
- Gemcitabine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin
Sep 15, 2023
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles
Not yet recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Biospecimen Collection
- +9 more
-
Los Angeles, CaliforniaYonemoto,Lisa
Jan 13, 2023
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Stereotactic body radiotherapy (SBRT)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Sep 15, 2023
Advanced NSCLC Trial in Spokane (Zimberelimab, Domvanalimab, Quemliclustat)
Recruiting
- Advanced Non-Small Cell Lung Cancer
- Zimberelimab
- +4 more
-
Spokane, WashingtonMedical Oncology Associates
Jan 5, 2023
Gastrointestinal Tract Malignancies Trial in Sarasota, Nashville (Zimberelimab, Domvanalimab, Fluorouracil)
Recruiting
- Gastrointestinal Tract Malignancies
- Zimberelimab
- +5 more
-
Phoenix, Arizona
- +26 more
Jan 20, 2023